Position in LEGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,511,217
+$8,989,898 QoQ
Shares Held
502,466
+64.6% QoQ
Ownership
0.258%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 218 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Derivatives in LEGN
reported options exposure · as of Jun 30, 2024CallValue
$894,658
CallShares
20,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. LEGN ranks #98 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in LEGN
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,511,217 | 502,466 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,521,319 | 305,214 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,883,063 | 224,612 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $32,964,110 | 1,010,859 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $36,255,021 | 1,021,556 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $32,612,665 | 961,175 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $31,890,435 | 980,038 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,755,888 | 118,118 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $894,658 | 20,200 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $5,298,809 | 119,639 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,901,451 | 33,900 | Call | Defined | 2024-05-13 | |
| 2024-03-31 | $7,186,025 | 128,116 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $18,005,450 | 299,243 | Shares | Defined | 2024-02-09 | |
| 2023-12-31 | $752,125 | 12,500 | Call | Defined | 2024-02-09 | |
| 2023-09-30 | $3,694,350 | 55,000 | Call | Defined | 2023-11-09 | |
| 2023-09-30 | $20,256,790 | 301,575 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,925,937 | 27,900 | Put | Defined | 2023-08-11 | |
| 2023-06-30 | $9,742,133 | 141,129 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,922,752 | 143,566 | Shares | Sole | 2023-05-12 | |
| 2023-03-31 | $1,345,338 | 27,900 | Put | Sole | 2023-05-12 | |
| 2022-12-31 | $5,494,044 | 110,057 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $4,010,272 | 98,291 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,869,150 | 88,530 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $3,691,962 | 101,595 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,773,050 | 102,404 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,864,527 | 56,656 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $94,004 | 2,290 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $53,890 | 1,857 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $55,475 | 1,970 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $36,056 | 1,168 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $21,280 | 500 | Shares | Defined | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||